PACB Pacific Biosciences of California Inc.

PacBio to Participate in the BofA Securities 2022 Healthcare Conference

PacBio to Participate in the BofA Securities 2022 Healthcare Conference

MENLO PARK, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- PacBio announced today that it will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada.

PacBio’s management is scheduled to present on Thursday, May 12 at 11:20 a.m. Pacific Time / 2:20 p.m. Eastern Time. The live webcast can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the presentation.

About PacBio

PacBio (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our existing HiFi long read sequencing and our emerging SBB® short read sequencing technologies. Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information please visit and follow @PacBio.

Contacts

Investors:

Todd Friedman

650.521.8450

Media:

Lizelda Lopez



EN
05/05/2022

Underlying

PACBPacific Biosciences of California Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Pacific Biosciences of California Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 46.92
BA BOEING COMPANY ...
BURL BURLINGTON STOR... ... (+25)

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

BA BOEING COMPANY (THE)
BURL BURLINGTON STORES INC.
DOV DOVER CORPORATION
WYNN WYNN RESORTS LIMITED
TGTX TG THERAPEUTICS INC.
SKX SKECHERS U.S.A. INC. CLASS A
PENN PENN NATIONAL GAMING INC.
PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC.
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
LVS LAS VEGAS SANDS CORP.
HVT HAVERTY FURNITURE COS. INC.
GPS GAP INC.
GGG GRACO INC.
BYD BOYD GAMING CORPORATION
BBY BEST BUY CO. INC.
AEO AMERICAN EAGLE OUTFITTERS INC.
ROST ROSINTER RESTAURANTS HOLDING ORD SHS
COLM COLUMBIA SPORTSWEAR COMPANY
MGM MGM RESORTS INTERNATIONAL
PVH PVH CORP.
ITT ITT INC.
RH RH
APTV APTIV PLC
KTB KONTOOR BRANDS
CZR CAESARS ENTERTAINMENT INC
11/16/22 November 16, 2022 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 46.92
ILMN ILLUMINA INC.
AMN AMN Healthcare ... ... (+33)

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

ILMN ILLUMINA INC.
AMN AMN HEALTHCARE SERVICES INC.
RLI RLI CORP.
PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC.
NVEC NVE CORP.
HBAN HUNTINGTON BANCSHARES INCORPORATED
FGEN FIBROGEN INC.
CVLG COVENANT LOGISTICS GROUP INC
CVI CVR ENERGY INC.
CROX CROCS INC.
BANF BANCFIRST
ASB ASSOCIATED BANC-CORP
CCRN CROSS COUNTRY HEALTHCARE INC.
LNC LINCOLN NATIONAL CORPORATION
SAM BOSTON BEER COMPANY INC. CLASS A
WFT.. WEATHERFORD INTERNATIONAL PLC
SRCE 1ST SOURCE CORP.
STBA S&T BANCORP INC.
AEHR AEHR TEST SYSTEMS
HCC WARRIOR MET COAL INC.
SMPL SIMPLY GOOD FOODS CO
RCUS ARCUS BIOSCIENCES
YMAB Y-MABS THERAPEUTICS
AMTB AMERANT BANCORP (A)
PAYA PAYA HOLDINGS INC (A)
KLXE KLX ENERGY SERVICES
VRT VERTIV HOLDINGS CO (A)
AMR ALPHA METALLURGICAL RESOURCES INC
VVNT VIVINT SMART HOME INC (A)
FA FIRST ADVANTAGE CORP NEW
CRCT CRICUT INC
JANX JANUX THERAPEUTICS INC
VIGL VIGIL NEUROSCIENCE INC
10/24/22 October 24, 2022 1 EN
 PRESS RELEASE
Free
PACB Pacific Bioscie...

PacBio Grants Equity Incentive Award to New Employee

PacBio Grants Equity Incentive Award to New Employee MENLO PARK, Calif., June 27, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of PacBio common stock, and restricted stock units (“RSUs”) covering 50,000 shares of PacBio common stock, to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity Incentive Plan (the “2020 Inducement Plan”...

June 28, 2022 1 EN
 PRESS RELEASE
Free
PACB Pacific Bioscie...

PacBio to Participate in the BofA Securities 2022 Healthcare Conferenc...

PacBio to Participate in the BofA Securities 2022 Healthcare Conference MENLO PARK, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- PacBio announced today that it will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada. PacBio’s management is scheduled to present on Thursday, May 12 at 11:20 a.m. Pacific Time / 2:20 p.m. Eastern Time. The live webcast can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the presentation. About PacBio PacBi...

May 5, 2022 1 EN
 PRESS RELEASE
Free
PACB Pacific Bioscie...

PacBio Announces First Quarter 2022 Financial Results

PacBio Announces First Quarter 2022 Financial Results MENLO PARK, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2022. First quarter results Revenue of $33.2 million, a 14% increase compared with $29.0 million in the prior year period.Delivered a record 50 Sequel II/IIe systems during the quarter compared to 41 Sequel II/IIe systems placed in the prior year quarter.Installed base of 424 Sequel II/IIe systems as of March 31, 2022, compared with 244 as of March 31, 2021.Instrument revenue of $15.6 million, c...

May 4, 2022 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch